知镜 Cognispect · 医学文献与研究工作台

Fasting-induced metabolic reprogramming as a therapeutic vulnerability in cancer: a systematic mechanistic review of in vitro evidence.

Bensalek R, Hassani Idrissi H, Ait Baha A, Hicham M, Akhouayri O, Habbane M, Benazzouz B.
Medical oncology (Northwood, London, England) · 2026-09-25 · PMID 42789187

文献摘要

Fasting and fasting-mimicking interventions have emerged as promising metabolic strategies in oncology. While preclinical evidence suggests enhanced tumor sensitivity to therapy, the mechanistic basis of fasting-induced anticancer effects remains incompletely defined. To systematically evaluate and synthesize in vitro evidence investigating the molecular and metabolic impact of fasting-based interventions on cancer cell models. A systematic review was conducted following PRISMA guidelines. Eligible studies investigated fasting-mimicking conditions, serum starvation or nutrient restriction in cancer cell lines. Risk of bias was assessed across predefined methodological domains. Eleven studies met inclusion criteria. Across diverse tumor types, fasting conditions consistently reduced IGF-1 signaling, inhibited PI3K/AKT/mTOR pathways, suppressed glycolysis, and induced AMPK-mediated stress responses. Cancer cells exhibited impaired proliferative capacity and increased sensitivity to chemotherapeutic agents under nutrient restriction. Despite methodological heterogeneity, mechanistic convergence across independent models was notable. Fasting induces a coordinated metabolic reprogramming that exposes intrinsic anabolic dependencies of malignant cells. These findings support the concept of fasting as a systems-level metabolic vulnerability strategy and warrant standardized translational investigation.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。